Meningitis vaccine labels and packages: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{Meningitis vaccine}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = http://dailymed.nlm.nih.gov/dailymed/...")
 
No edit summary
 
Line 2: Line 2:
{{Meningitis vaccine}}
{{Meningitis vaccine}}
{{CMG}}; {{AE}} {{chetan}}
{{CMG}}; {{AE}} {{chetan}}
==Labels And Packages==
Principal Display Panel - Vial Label
MenA Lyophilized
Conjugate Component
NOT TO BE USED ALONE
Reconstitute with
MenCYW-135 Liquid Conjugate
Component to form Menveo
NDC 46028-218-11
Novartis Vaccines
Rx Only
{|
|-
| [[File:|800px|thumb]]
|-
|}
Principal Display Panel - Vial Label
MenCYW-135 Liquid
Conjugate Component
Not to be used alone
Use to reconstitute MenA
Lyophilized Conjugate
Component to form Menveo
NDC 46028-219-11
Novartis Vaccines
{|
|-
| [[File:|800px|thumb]]
|-
|}
Principal Display Panel - Package Label
Meningococcal (Groups A, C, Y and W-135)
Oligosaccharide
Diphtheria CRM197 Conjugate Vaccine
MENVEO ®
For use in persons 2 months through 55 years of age
Powder and solvent
for injection
NDC 46028-208-01
Rx Only
===Novartis Vaccines Contains===
Five doses (10 vials) per package. One dose consists of 1 vial of MenA
Lyophilized Conjugate Component to be reconstituted with 1 vial of
MenCYW-135 Liquid Conjugate Component. No preservatives.
NEITHER MenCYW-135 NOR MenA COMPONENT TO BE USED ALONE
===One dose (0.5 ml) contains===
*Meningococcal group A oligosaccharide........................10 micrograms
*Meningococcal group C oligosaccharide.......................... 5 micrograms
*Meningococcal group Y oligosaccharide.......................... 5 micrograms
*Meningococcal group W-135 oligosaccharide................. 5 micrograms
conjugated to CRM197 protein
Store refrigerated, away from the freezer compartment, at 36°F to 46°F
(2°C to 8°C), protect from light
For intramuscular injection. Read the package leaflet before use.
Manufactured by
Novartis Vaccines and Diagnostics S.r.l. Bellaria-Rosia 53018 Sovicille (SI), Italy
Distributed by
Novartis Vaccines and Diagnostics Inc., 350 Massachusetts Avenue, Cambridge,
MA 02139
US License No. 1751
{|
|-
| [[File:|800px|thumb]]
|-
|}




Latest revision as of 15:32, 9 January 2014

Meningitis vaccine
MENVEO® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Labels And Packages

Principal Display Panel - Vial Label

MenA Lyophilized

Conjugate Component

NOT TO BE USED ALONE

Reconstitute with

MenCYW-135 Liquid Conjugate

Component to form Menveo

NDC 46028-218-11

Novartis Vaccines

Rx Only

[[File:|800px|thumb]]

Principal Display Panel - Vial Label

MenCYW-135 Liquid

Conjugate Component

Not to be used alone

Use to reconstitute MenA

Lyophilized Conjugate

Component to form Menveo

NDC 46028-219-11

Novartis Vaccines

[[File:|800px|thumb]]


Principal Display Panel - Package Label

Meningococcal (Groups A, C, Y and W-135)

Oligosaccharide

Diphtheria CRM197 Conjugate Vaccine

MENVEO ®

For use in persons 2 months through 55 years of age

Powder and solvent

for injection

NDC 46028-208-01

Rx Only

Novartis Vaccines Contains

Five doses (10 vials) per package. One dose consists of 1 vial of MenA

Lyophilized Conjugate Component to be reconstituted with 1 vial of

MenCYW-135 Liquid Conjugate Component. No preservatives.

NEITHER MenCYW-135 NOR MenA COMPONENT TO BE USED ALONE

One dose (0.5 ml) contains

  • Meningococcal group A oligosaccharide........................10 micrograms
  • Meningococcal group C oligosaccharide.......................... 5 micrograms
  • Meningococcal group Y oligosaccharide.......................... 5 micrograms
  • Meningococcal group W-135 oligosaccharide................. 5 micrograms

conjugated to CRM197 protein

Store refrigerated, away from the freezer compartment, at 36°F to 46°F

(2°C to 8°C), protect from light

For intramuscular injection. Read the package leaflet before use.

Manufactured by

Novartis Vaccines and Diagnostics S.r.l. Bellaria-Rosia 53018 Sovicille (SI), Italy

Distributed by

Novartis Vaccines and Diagnostics Inc., 350 Massachusetts Avenue, Cambridge,

MA 02139

US License No. 1751

[[File:|800px|thumb]]


[1]


References

  1. ↑ "http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=89dde472-1efb-4630-88bc-41cde216fb3a". External link in |title= (help)

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Meningitis_vaccine_labels_and_packages&oldid=930182"